Both Leonard, Collins Sarah, de Zoysa Aruni, White Joanne, Mandal Sema, Efstratiou Androulla
WHO Global Reference Centre for Diphtheria and Streptococcal Infections, Public Health England (PHE), London, United Kingdom.
Immunisation, Hepatitis and Blood Safety Department, Centre for Infectious Disease Surveillance and Control, Public Health England (PHE), London, United Kingdom.
J Clin Microbiol. 2015 Feb;53(2):567-72. doi: 10.1128/JCM.03398-14. Epub 2014 Dec 10.
Human infections caused by toxigenic corynebacteria occur sporadically across Europe. In this report, we undertook the epidemiological and molecular characterization of all toxigenic corynebacterium strains isolated in England between January 2007 and December 2013. Epidemiological aspects include case demographics, risk factors, clinical presentation, treatment, and outcome. Molecular characterization was performed using multilocus sequence typing (MLST) alongside traditional phenotypic methods. In total, there were 20 cases of toxigenic corynebacteria; 12 (60.0%) were caused by Corynebacterium ulcerans, where animal contact was the predominant risk factor. The remaining eight (40.0%) were caused by Corynebacterium diphtheriae strains; six were biovar mitis, which were associated with recent travel abroad. Adults 45 years and older were particularly affected (55.0%; 11/20), and typical symptoms included sore throat and fever. Respiratory diphtheria with the absence of a pharyngeal membrane was the most common presentation (50.0%; 10/20). None of the eight C. diphtheriae cases were fully immunized. Diphtheria antitoxin was issued in two (9.5%) cases; both survived. Two (9.5%) cases died, one due to a C. diphtheriae infection and one due to C. ulcerans. MLST demonstrated that the majority (87.5%; 7/8) of C. diphtheriae strains represented new sequence types (STs). By adapting several primer sequences, the MLST genes in C. ulcerans were also amplified, thereby providing the basis for extension of the MLST scheme, which is currently restricted to C. diphtheriae. Despite high population immunity, occasional toxigenic corynebacterium strains are identified in England and continued surveillance is required.
产毒棒状杆菌引起的人类感染在欧洲各地偶有发生。在本报告中,我们对2007年1月至2013年12月期间在英格兰分离出的所有产毒棒状杆菌菌株进行了流行病学和分子特征分析。流行病学方面包括病例人口统计学、危险因素、临床表现、治疗及转归。分子特征分析采用多位点序列分型(MLST)并结合传统表型方法。总共20例产毒棒状杆菌感染病例;12例(60.0%)由溃疡棒状杆菌引起,动物接触是主要危险因素。其余8例(40.0%)由白喉棒状杆菌菌株引起;6例为轻型生物变种,与近期出国旅行有关。45岁及以上成年人受影响尤为严重(55.0%;11/20),典型症状包括咽痛和发热。无咽膜的呼吸道白喉是最常见的表现形式(50.0%;10/20)。8例白喉棒状杆菌病例均未完全免疫。2例(9.5%)病例使用了白喉抗毒素;均存活。2例(9.5%)病例死亡,1例死于白喉棒状杆菌感染,1例死于溃疡棒状杆菌感染。MLST显示,大多数(87.5%;7/8)白喉棒状杆菌菌株代表新的序列类型(STs)。通过调整几个引物序列,也扩增出了溃疡棒状杆菌中的MLST基因,从而为扩展目前仅限于白喉棒状杆菌的MLST方案提供了基础。尽管人群免疫力较高,但在英格兰仍偶有发现产毒棒状杆菌菌株,因此需要持续监测。